Skip to content
Editorial Open access

Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults: From Oncologic Benefit to Net Clinical Benefit

Sep 2026 · Digestive Endoscopy · Vol 38 · 0 citations · 8 references
Medicine

Abstract

Following the endoscopic resection of pT1 colorectal cancer, additional surgery with lymph node dissection is recommended for patients with pathological features associated with an increased risk of lymph node metastasis (LNM) [1]. This strategy is supported by substantial evidence showing that established pathological risk factors identify patients at increased oncological risk and that additional surgery is associated with improved long-term outcomes, including disease-specific survival (DSS) and overall survival (OS), in appropriately selected patients [2]. A recent meta-analysis by Chen et al. demonstrated that surgical resection was associated with improved DSS compared to local resection, although this benefit became more apparent only after prolonged follow-up [3]. The 5-year DSS rates were similar between the two groups (96.7% vs. 98.3%), whereas a more substantial difference emerged after 10 years (86.9% vs. 97.1%). In contrast, the corresponding differences in OS remained relatively modest (86.3% vs. 94.5% at 5 years and 72.9% vs. 84.4% at 10 years), reflecting the influence of competing mortality. These findings suggest that the oncological benefits of surgery accumulate gradually over time and may not be fully realized in older adults with limited life expectancy and a high risk of competing mortality. In a real-world setting, among patients aged ≥ 80 years with high-risk pT1 colorectal cancer, there was no significant difference in OS between

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.